SCHEMBL4193922

SCHEMBL4193922

CC(CC1CCOCC1)NCc1ccccc1NS(=O)(=O)c1cc2ccccc2s1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 1/20 0.40
GHSR Q92847 1/20 0.37
MCL1 Q07820 1/20 0.37
HDAC1 Q13547 1/20 0.34
DRD2 P14416 3/20 0.34
HTR2A P28223 3/20 0.34
MMP13 P45452 1/20 0.34
HTR1A P08908 1/20 0.34
F10 P00742 2/20 0.34
KDM4E B2RXH2 1/20 0.33
PKM P14618 1/20 0.33
CA2 P00918 1/20 0.33
KIT P10721 2/20 0.33
RORC P51449 2/20 0.33
PI4KB Q9UBF8 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HTR7 P34969 2/20 0.32
HTR6 P50406 2/20 0.32
NPY5R Q15761 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4184166 0.93 CCR2 (0.43) CCR2GHSRMCL1HDAC1DRD2
SCHEMBL4192385 0.92 CCR2 (0.41) CCR2GHSRMCL1HDAC1DRD2
SCHEMBL4197675 0.91 CCR2 (0.41) CCR2GHSRMCL1HDAC1DRD2
SCHEMBL4195304 0.91 CCR2 (0.41) CCR2GHSRMCL1HDAC1DRD2
SCHEMBL4200095 0.91 CCR2 (0.41) CCR2GHSRMCL1HDAC1DRD2
SCHEMBL4198286 0.82 KDM4E (0.36) CCR2GHSRMCL1DRD2HTR2A
SCHEMBL4190584 0.82 GHSR (0.41) CCR2GHSRDRD2HTR2AHTR1A
SCHEMBL4190303 0.82 CA2 (0.37) CCR2GHSRMCL1HDAC1DRD2
SCHEMBL4186605 0.81 LMNA (0.41) CCR2GHSRDRD2HTR2AHTR1A
SCHEMBL4192467 0.81 KDM4E (0.38) CCR2GHSRMCL1DRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 CCR2 4308/4885GHSR 3645/4885MCL1 1066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.